According to one source we'll see something Tuesday, Jan

New Post Public Reply Private Reply Replies (1) Message Board
Megashear Badgerbob #254
326
According to one source we'll see something Tuesday, Jan 29th. Then Jan 31st is the audio interview they are touting. There are new images on the Mexus website under Santa Elena II showing prep work for a new blasting program on the Julio vein.

Signs point to a significant infusion of funds -- some probably from a round of PP subscriptions but I'd guess new funds arrived to get equipment moved back to Santa Elena and to sign a contract for more blasting - and rehab of a portion of the leach pad to get new ore under leach fairly soon. I see evidence of more money than Mexus could have obtained on its own. They also paid off a 100K short -term loan. Assume help from Itronics investors or principals.

So many missteps- we are now paying good money after bad to correct past mistakes. If the accumulated loses over the past 10 years had all been spent in one place first with a larger drill program and then a professionally done mine plan we would have been in production maybe six years ago.

No proof yet we have an economic resource. Looks like we're back to "go it almost alone" I don't think Itronics is going to be an operating partner -more of a promotion partner and maybe mostly to benefit Itronics. I anticipate dilution of our shares again since there are over a billion shares available in the latest authorization. The share count is such that nobody's holdings amount to much - even the 10 million and above shareholders have had their stake diminished by the present and future dilution. The max potential for this is down considerably from any share price we used to think of as attainable. One dollar- never unless there is a sig reverse split.. Recall 65 cents that was touted and acceted? Forget that one too. I don't know the max potential but it's probably in the tens of cents like 15 or 25 cents max in current share structure. Tha'ts still a penny stock and still OTC. And we have to get to one cent first so a very long way to go for most to see green with this investment.

Some are adding heavily at sub-penny to bring cost basis down. I'd say add but bail, when you get a double on the new money, added. Don't get greedy - take profit when you have it. Use stops on your new money and don't add to your losses.

I'm still looking for those 3 to 5 OUNCE assays we've heard about for nine years. I think now that was more marketing than geology as with much of Mexus to date.



Mexus Gold US (MXSG) Stock Research Links

MXSG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading